---
figid: PMC11815446__openhrt-12-1-g001
figtitle: Metabolic pathway of Clopidogrel
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11815446
filename: openhrt-12-1-g001.jpg
figlink: /pmc/articles/PMC11815446/figure/F1/
number: F1
caption: Metabolic pathway of Clopidogrel
papertitle: Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic
  limitations of clopidogrel
reftext: Anil Pareek, et al. Open Heart. 2025;12(1).
year: '2025'
doi: 10.1136/openhrt-2024-003088
journal_title: Open Heart
journal_nlm_ta: Open Heart
publisher_name: BMJ Publishing Group
keywords: Acute Coronary Syndrome | Genetics | Pharmacology, Clinical | Translational
  Medical Research
automl_pathway: 0.8577067
figid_alias: PMC11815446__F1
figtype: Figure
redirect_from: /figures/PMC11815446__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11815446__openhrt-12-1-g001.html
  '@type': Dataset
  description: Metabolic pathway of Clopidogrel
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP2C19
  - CYP1A2
  - CYP2B6
  - PTPN5
  - CES1
  - RNGTT
  - CYP3A4
  - CYP2C9
  - Clopidogrel
---
